Minerva Biotechnologies Gets FDA Approval of IND for a MUC1*-CAR-1XX
09 Jan 2023 //
BUSINESSWIRE
Minerva Begins 1st-In-Human Phase I/II Trial of MUC1 star Targeting CAR T
01 Feb 2022 //
BUSINESSWIRE
Minerva Neurosciences Reports Second Quarter 2021 Financial Results
02 Aug 2021 //
GLOBENEWSWIRE
Minerva Surgical Issues Update on ?U.S. Supreme Court Ruling
30 Jun 2021 //
PR NEWSWIRE